173 related articles for article (PubMed ID: 8229473)
1. Denys-Drash syndrome: relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1.
Coppes MJ; Huff V; Pelletier J
J Pediatr; 1993 Nov; 123(5):673-8. PubMed ID: 8229473
[No Abstract] [Full Text] [Related]
2. "Molecular genetic analysis of the WT1 gene in patients suspected to have the Denys-Drash syndrome".
Coppes MJ; Clericuzio CL
Med Pediatr Oncol; 1994; 23(4):390. PubMed ID: 8093189
[No Abstract] [Full Text] [Related]
3. A novel mutation of the WT1 gene (a tumor suppressor gene for Wilms' tumor) in a patient with Denys-Drash syndrome.
Sakai A; Tadokoro K; Yanagisawa H; Nagafuchi S; Hoshikawa N; Suzuki T; Kohsaka T; Hasegawa T; Nakahori Y; Yamada M
Hum Mol Genet; 1993 Nov; 2(11):1969-70. PubMed ID: 8281164
[No Abstract] [Full Text] [Related]
4. [Glomerulopathy in Denys-Drash syndrome. Case report of a model disease].
Stallmach T; Neuhaus TJ; Kösters R; Hailemariam S
Pathologe; 1998 May; 19(3):230-4. PubMed ID: 9648150
[TBL] [Abstract][Full Text] [Related]
5. A novel mutation H373Y in the Wilms' tumor suppressor gene, WT1, associated with Denys-Drash syndrome.
Ghahremani M; Chan CB; Bistritzer T; Aladjem MM; Tieder M; Pelletier J
Hum Hered; 1996; 46(6):336-8. PubMed ID: 8956030
[No Abstract] [Full Text] [Related]
6. Further evidence that imbalance of WT1 isoforms may be involved in Denys-Drash syndrome.
König A; Jakubiczka S; Wieacker P; Schlösser HW; Gessler M
Hum Mol Genet; 1993 Nov; 2(11):1967-8. PubMed ID: 8281163
[No Abstract] [Full Text] [Related]
7. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetics of Wilms' tumour.
Tay JS
J Paediatr Child Health; 1995 Oct; 31(5):379-83. PubMed ID: 8554853
[TBL] [Abstract][Full Text] [Related]
9. The novel WT1 gene mutation p.H377N associated to Denys-Drash syndrome.
Guaragna MS; Soardi FC; Assumpção JG; Zambaldi Lde J; Cardinalli IA; Yunes JA; de Mello MP; Brandalise SR; Aguiar Sdos S
J Pediatr Hematol Oncol; 2010 Aug; 32(6):486-8. PubMed ID: 20562648
[TBL] [Abstract][Full Text] [Related]
10. A novel insertional mutation at the third zinc finger coding region of the WT1 gene in Denys-Drash syndrome.
Ogawa O; Eccles MR; Yun K; Mueller RF; Holdaway MD; Reeve AE
Hum Mol Genet; 1993 Feb; 2(2):203-4. PubMed ID: 8098976
[No Abstract] [Full Text] [Related]
11. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.
Pelletier J; Bruening W; Kashtan CE; Mauer SM; Manivel JC; Striegel JE; Houghton DC; Junien C; Habib R; Fouser L
Cell; 1991 Oct; 67(2):437-47. PubMed ID: 1655284
[TBL] [Abstract][Full Text] [Related]
12. Inherited WT1 mutation in Denys-Drash syndrome.
Coppes MJ; Liefers GJ; Higuchi M; Zinn AB; Balfe JW; Williams BR
Cancer Res; 1992 Nov; 52(21):6125-8. PubMed ID: 1327525
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations.
Schumacher V; Schärer K; Wühl E; Altrogge H; Bonzel KE; Guschmann M; Neuhaus TJ; Pollastro RM; Kuwertz-Bröking E; Bulla M; Tondera AM; Mundel P; Helmchen U; Waldherr R; Weirich A; Royer-Pokora B
Kidney Int; 1998 Jun; 53(6):1594-600. PubMed ID: 9607189
[TBL] [Abstract][Full Text] [Related]
14. A newly identified exonic mutation of the WT1 gene in a patient with Denys-Drash syndrome.
Tsuda M; Sakiyama T; Owada M; Chiba Y
Acta Paediatr Jpn; 1996 Jun; 38(3):265-6. PubMed ID: 8741319
[TBL] [Abstract][Full Text] [Related]
15. Nephropathy with Wilms tumour or gonadal dysgenesis: incomplete Denys-Drash syndrome or separate diseases?
Schmitt K; Zabel B; Tulzer G; Eitelberger F; Pelletier J
Eur J Pediatr; 1995 Jul; 154(7):577-81. PubMed ID: 7556327
[TBL] [Abstract][Full Text] [Related]
16. Genetic Testing Proves Crucial in Case of Ambiguous Genitalia and Renal Masses.
Weaver J; Rove KO; Meenakshi-Sundaram B; Vricella GJ
Urology; 2019 Jul; 129():194-196. PubMed ID: 30914336
[TBL] [Abstract][Full Text] [Related]
17. Genetics of the nephrotic syndrome.
Salomon R; Gubler MC; Niaudet P
Curr Opin Pediatr; 2000 Apr; 12(2):129-34. PubMed ID: 10763762
[TBL] [Abstract][Full Text] [Related]
18. WT1 mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominant-negative fashion.
Bardeesy N; Zabel B; Schmitt K; Pelletier J
Genomics; 1994 Jun; 21(3):663-4. PubMed ID: 7959750
[No Abstract] [Full Text] [Related]
19. Atypical presentation of Denys-Drash syndrome in a female with a novel Wt1 gene mutation.
Machin GA
Birth Defects Orig Artic Ser; 1996; 30(1):269-86. PubMed ID: 9125334
[No Abstract] [Full Text] [Related]
20. WT1 splice site mutation in a 46,XX female with minimal-change nephrotic syndrome and Wilms' tumour.
Loirat C; André JL; Champigneulle J; Acquaviva C; Chantereau D; Bourquard R; Elion J; Denamur E
Nephrol Dial Transplant; 2003 Apr; 18(4):823-5. PubMed ID: 12637656
[No Abstract] [Full Text] [Related]
[Next] [New Search]